Share >  
Share
Share on Tumblr

Paonta Sahib

News »

   latest by relevance
Ranbaxy shrs fall on USD 500mn US lawsuits settlement
May 14, 2013 at 09:31 | Source: Moneycontrol.com
Ranbaxy said its US arm is pleading guilty to criminal charges related to violation of the Food, Drugs and Cosmetics Act and the company. owned by Japan's Daiichi Sankyo, will now pay USD 500 million to settle all the civil, criminal lawsuits.
Ranbaxy puts past to rest, bright future ahead: Macquarie
Dec 22, 2011 at 12:25 | Source: CNBC-TV18
Pharma analyst at Macquarie Research, Abhishek Singhal, spoke to CNBC-TV18 about the key takeaways from the management meet post Ranbaxys settlement with the US FDA.
Ranbaxy US settlement positive, but penalty high: Analysts
Dec 22, 2011 at 10:11 | Source: Moneycontrol.com
Ranbaxy's consent decree with the US Food and Drugs Administration [FDA] to resolve its long pending issue related to the drug regulator blacklisting its plants in Dewas and Paonta Saheb is a positive step analysts say.
Ranbaxy's roller coaster ride on settlement with US FDA
Dec 21, 2011 at 17:09 | Source: Moneycontrol.com
Ranbaxy shares ended 3% up on Wednesday in a roller coaster ride after the drug maker signed a consent decree with US FDA, and set aside USD 500 million to cover any liabilities arising from a US Justice Department probe.
Ranbaxy falls as US settlement provision to hurt earnings
Dec 21, 2011 at 11:56 | Source: Moneycontrol.com
Shares of Ranbaxy Laboratories fell over 3% on Wednesday after the drug maker said it has signed a consent decree with the US Food and Drug Administration [FDA] and also has separately set aside USD 500 million to cover any potential penalty from an investigation by the US Justice Department.
Ranbaxy jumps after final nod from USFDA to launch Lipitor
Dec 01, 2011 at 10:34 | Source: Moneycontrol.com
Ranbaxys shares jumped over 10% in morning trade on Thursday after it said it has launched its generic version of Lipitor in the US market having received final approval from US Food and Drugs Administration (FDA).

Videos »
Ranbaxy puts past to rest, bright future ahead: Macquarie
Ranbaxy may have to pay $1 bn to settle FDA fines: Fortune
Ranbaxy may offer penalty to US FDA for lifting export ban
How do brokerages view Ranbaxy
Pharma buzz: Sector outlook, cos to look at
more »

Photos »

  /  
Interact & exchange stock tips & market info »

brokeramitb
ack

Platinum Member

185 Followers

Commodities  

Trading kaisi chal rahi hai hai suhana mai paonta sahib ...

10.37 PM Mar 6th

ahmak

Platinum Member

38 Followers

Ranbaxy Labs  

No up move till launch of Diovan and approvals for paonta sa...

12.35 PM Feb 27th

dravtar

Silver Member

3 Followers

Himalaya Inter  

Today, only I had a packet of LASSi marketed by Reliance Food Products...

5.50 PM Jun 20th 2012

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window